Interview with Yves Groult, Managing Director, Boiron Hungary
Hungary has one of the oldest drug industries in Europe, but homeopathy too has quite a history in the country, with the Homoeopathic Doctor’s Association being founded as early as…
Address: Ady Endre Ut 8 H-1024 Budapest,Hungary
Tel: +36 1 365 1430
Company allapillére way back to health with concrete ideas. More than 50 countries throughout the world for thousands of people’s determination and dedication mean performance is key.
French company, we are szakterületünkön, the world leader in homeopathic medicines. In France, four manufacturing sites and 32 industrial preparation and marketing of a need.
The company – like other companies – currently live in troubled times, but we are confident that it can bring positive changes in the long run, especially in medicine, but the pharmaceutical industry and health care management field.
As a family company we make every effort to adapt to the industry’s difficulties. Humbly, but we try to give you a chance gyógyszereinknek determination, to show their usefulness and efficiency. The French pharmaceutical market is less than 1% of you have … this shows how much we have the opportunity to grow!
A homeopathic preparation of a mono (rarely more) ingredients. The raw material of plant, mineral and animal origin can be.
The Latin name of the homeopathic remedies, the main raw material used to manufacture internationally known scientific names. The Latin name is due to the international homeopathic medicines in all countries of the same name.
The number on the tube dilution őstinktúra your area. The initials represent the type of dilution (C = one hundred times (centezimális) dilution, H = Hahnemann method of preparation)
The mono homeopathic preparations usually used several times in tubes or pellets számlálós-dose disposable containers, and sometimes liquid droplets (or őstinktúra homeopathic dilution) in the form can be purchased. The pharmaceutical industry is also found in other forms of production in homeopathy, but expect much less widespread.
Hungary has one of the oldest drug industries in Europe, but homeopathy too has quite a history in the country, with the Homoeopathic Doctor’s Association being founded as early as…
Anna Wienner, general manager of IBSA Hungary, gives an update on the recent activities and achievement of the affiliate since her previous interview in 2016. Furthermore, Wienner goes on to…
Norbert Langen, founder and CEO of Phytotec, a Hungarian distributor of evidence-based natural Rx and OTC drugs, introduces the company and its unique approach to marketing non-chemically formulated pharmaceuticals in…
Dr Ildikó Horvath, Hungary’s State Secretary for Health explains her role and shares insights on the key health trends in Hungary, the government’s top priority in improving healthcare, the importance…
Here we highlight five of the most important women working in healthcare and the life sciences in Central & Eastern Europe (CEE) today. From regulators to pharma affiliate heads with…
As the only one of Hungary’s four historical pharmaceutical manufactures to have resisted international acquisition, Gedeon Richter stands alone as the country’s national champion. However, the company does not exist…
Established in Hungary in 1913, Egis is a traditional Central Eastern European pharmaceutical company with an international footprint across the globe. As one of the four largest historical pharma companies…
Gábor Orbán, CEO of Gedeon Richter, highlights the recent turnaround of the company’s performance, its exciting new collaboration with Allergan in the US market, and the landmark launch of Gedeon’s…
Dr Péter Holchacker, director of the Hungarian Association of Innovative Pharmaceutical Manufacturers (AIPM), shares his insights on the key activities of the organisation, the collaborations it fosters with authorities and…
Attila Lukács, general manager Hungary, Romania, Bulgaria for CSL Behring outlines emergent trends in the Hungarian plasma medication market, how the affiliate has succeeded in becoming a partner to patient…
Laszlo Dinca, managing director of Vanessa Research – Hungary, shares his insights on the company’s rare and orphan disease portfolio; the intentions behind the acquisition of Hungaro-Gal Pharmaceutical Manufacturing [HG…
Irma Veberic, general manager of Roche Hungary, gives her insights on the key issues being faced by the Hungarian healthcare system and the company’s role as a partner in improving…
István Peták, co-founder and CEO of Oncompass introduces the innovative start-up and elaborates on how its solution for digital treatment planning and digital biomarkers can revolutionize not only personalized oncology…
See our Cookie Privacy Policy Here